Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.
about
Attenuation of inflammatory polyarthritis in TNF transgenic mice by diacerein: comparative analysis with dexamethasone, methotrexate and anti-TNF protocolsThe role of osteoprotegerin in arthritisEffect of phospholipase A2 inhibitory peptide on inflammatory arthritis in a TNF transgenic mouse model: a time-course ultrastructural studyTumour necrosis factor activates the mitogen-activated protein kinases p38alpha and ERK in the synovial membrane in vivoAnimal Models of Bone Loss in Inflammatory Arthritis: from Cytokines in the Bench to Novel Treatments for Bone Loss in the Bedside-a Comprehensive ReviewRANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesThe synovio-entheseal complex in enthesoarthritis.Promising bone-related therapeutic targets for rheumatoid arthritis.Mediation of nonerosive arthritis in a mouse model of lupus by interferon-alpha-stimulated monocyte differentiation that is nonpermissive of osteoclastogenesis.Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment.Bone damage in rheumatoid arthritis: mechanistic insights and approaches to preventionTumor necrosis factor is a therapeutic target for immunological unbalance and cardiac abnormalities in chronic experimental Chagas' heart disease.Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis.Circulating mediators of bone remodeling in psoriatic arthritis: implications for disordered osteoclastogenesis and bone erosion.Genetic deficiency of Syk protects mice from autoantibody-induced arthritis.Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis.Anti-TNFα domain antibody construct CEP-37247: Full antibody functionality at half the size.Extraintestinal manifestations in inflammatory bowel disease.A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone lossSecondary osteoporosis in patients with juvenile idiopathic arthritis.Radiographic severity of rheumatoid arthritis in African Americans: results from a multicenter observational study.Osteoclasts are essential for TNF-alpha-mediated joint destruction.Role of RANKL and RANK in bone loss and arthritis.Bone destruction in arthritis.Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis.Osteoporosis in the rheumatic disease patient.The phosphoinositide 3-kinase isoform PI3Kβ regulates osteoclast-mediated bone resorption in humans and mice.Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis.T-cell involvement in osteoclast biology: implications for rheumatoid bone erosion.Bone Loss Triggered by the Cytokine Network in Inflammatory Autoimmune Diseases.Positive regulators of osteoclastogenesis and bone resorption in rheumatoid arthritisInfections in postmenopausal women with osteoporosis treated with denosumab or placebo: coincidence or causal association?TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 ExpressionCells of the synovium in rheumatoid arthritis. OsteoclastsTNF-induced structural joint damage is mediated by IL-1.Review article: bone disease in inflammatory bowel disease.Erosive arthritis.RANK, RANKL and osteoprotegerin in arthritic bone loss.Brucella abortus invasion of osteoblasts inhibits bone formation.Hand bone densitometry: a more sensitive standard for the assessment of early bone damage in rheumatoid arthritis.
P2860
Q24793159-75D5AC76-3177-40CF-BC5D-7E3F53B93B70Q24797889-27BDA7CF-48CF-4506-B7C6-E13F596B9B42Q24801037-A749553F-4CD9-415A-A1D9-78F255312E5AQ24812465-7107F215-2759-4439-9C54-4CD3FAD08477Q26774874-3CE97820-E557-4C75-8EA2-49493E51741CQ28570898-78731D92-B4BD-432F-BB97-56AB3AD7D896Q33360030-0385F0DC-3D05-419D-91B7-DB52A23D701DQ33554023-798A4853-495F-4C3E-95A7-9F3472E3BED0Q33790174-EBDE23EB-F376-4D11-AFC0-D47683F829F1Q33896725-0B2F317F-1FEC-4EC3-ACA2-39CD53D8D37EQ34001621-A615E180-1D23-4C3C-84AC-51FB2CD47DA7Q34032964-A4C5FC37-4D29-4CA8-85D1-2191C42704C6Q34140190-64D8B4B4-1F0A-4C47-B3CE-4CF498122185Q34153144-C47A4EED-0F63-4F7A-93CF-31FA23613933Q34275410-3EE8F9E7-E3E7-4E5F-B259-9EB5E6D1AA52Q34336558-CBD15FCF-102D-43E0-A5DB-354272270F05Q34445142-81D596F9-A9BB-45EA-B33F-53446FE0D731Q34488386-A052A678-76A2-40C4-B277-D44D1B5BCC7DQ34567407-8EA318B8-61E4-4494-817C-3D38B48CB2F6Q34595120-D3373F7D-7160-45CD-B25E-A7443D2388C9Q34642952-59A9F0AC-9D7E-424C-A4F7-C16247E58E8BQ34826003-0F9E8B6A-A93A-4369-BB46-D29F1728F107Q34963016-8936EFF1-D658-419A-88FE-CD576C41E492Q34963176-2920FF7C-1C06-499A-B4EF-11E8399EE7D6Q34967810-70181D68-3C67-4F28-A638-4E5C354749A9Q34986976-4644821D-CBCF-425C-B9C6-BBB33DD47873Q35040987-4B8853CE-579E-4FE6-8F26-CB00D75E5ACCQ35083436-80317A93-65FE-44AA-8290-446E3EC9E8ECQ35179608-93543020-208E-488B-BF6A-BD585B6FB745Q35614331-16D3CC8C-EE2D-48C6-ACB0-FAE09311A613Q35617594-45DB4EAF-E083-4C75-8C83-FC1B408B7033Q35643989-4B89D6D3-9A41-4940-84D8-FFE65FE6195AQ35750113-2CEACEF8-101A-4684-89BD-17F3DD68327DQ35769060-7B2651B0-5555-41CC-9712-72B1AC3F1E3CQ35880188-1FD233BB-37D4-4682-AA96-A505D6B0B65EQ35880384-C453B440-87B0-4B90-BC26-8B36AD209AEDQ35901078-C1EC767B-2F10-4789-8E08-E2E151DE8142Q36078073-7EB64900-AB6F-48CB-A0A1-4324F2AC6F4BQ36155934-0E54C5CB-DCE7-420B-8800-786BF50B6CBAQ36204174-DC90D59B-AEF5-4C45-91D0-1A495A109096
P2860
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Tumor necrosis factor alpha-me ...... eoclasts with osteoprotegerin.
@en
Tumor necrosis factor alpha-me ...... eoclasts with osteoprotegerin.
@nl
type
label
Tumor necrosis factor alpha-me ...... eoclasts with osteoprotegerin.
@en
Tumor necrosis factor alpha-me ...... eoclasts with osteoprotegerin.
@nl
prefLabel
Tumor necrosis factor alpha-me ...... eoclasts with osteoprotegerin.
@en
Tumor necrosis factor alpha-me ...... eoclasts with osteoprotegerin.
@nl
P2093
P2860
P50
P356
P1476
Tumor necrosis factor alpha-me ...... eoclasts with osteoprotegerin.
@en
P2093
Andrea Maier
Birgit Türk
Günter Steiner
Kurt Redlich
Makiyeh Tohidast-Akrad
Peter Pietschmann
Silva Haralambous
Silvia Hayer
Susanne Lang
Wolfgang Woloszczuk
P2860
P304
P356
10.1002/ART.10097
P577
2002-03-01T00:00:00Z